Cindy Jacobs
2018
In 2018, Cindy Jacobs earned a total compensation of $712.2K as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,270 |
|---|---|
| Option Awards | $118,707 |
| Salary | $413,230 |
| Total | $712,207 |
Jacobs received $413.2K in salary, accounting for 58% of the total pay in 2018.
Jacobs also received $180.3K in non-equity incentive plan and $118.7K in option awards.
Rankings
In 2018, Cindy Jacobs' compensation ranked 10,643rd out of 14,244 executives tracked by ExecPay. In other words, Jacobs earned more than 25.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,643 out of 14,244 | 25th |
Division Manufacturing | 4,289 out of 5,762 | 26th |
Major group Chemicals And Allied Products | 1,617 out of 2,125 | 24th |
Industry group Drugs | 1,366 out of 1,814 | 25th |
Industry In Vitro and In Vivo Diagnostic Substances | 49 out of 72 | 32nd |
Source: SEC filing on March 28, 2019.
Jacobs' colleagues
We found three more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2018.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019